Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA ...( Utilizing Leptospermum Honey Algina...),Health
"Utilizing Leptospermum Honey Alginate in Treatment of Recalcitrant Lower Extremity Ulcers", Dr. Steven J. Kavros, DPM, Mayo Clinic, Rochester, MN.
In addition to these presentations, the first topic on the conference's general session agenda following the keynote address will be "MEDIHONEY(TM): An Update on the Newly Approved Natural Approach to Chronic Wounds", to be presented by Dr. Robert Frykberg, DPM, FAPWCA, MPH, Chief of Podiatry, Carl T. Hayden VA Medical Center in Phoenix, AZ. In this session Dr. Frykberg will be providing an update on his continuing case series related to the treatment of recalcitrant diabetic foot ulcers with MEDIHONEY(TM) dressings, first presented at the Clinical Symposium on Advances in Skin and Wound Care last October.
MEDIHONEY is the first FDA-cleared honey-based dressing for use on chronic wounds and burns, and is the only FDA-cleared honey-based product currently commercialized. Its key ingredient, Active Leptospermum Honey, has been shown to be effective in a variety of wounds and burns, and was recently the focus of two positive large scale randomized controlled studies on leg ulcers. After four months on the market, the company has made the decision to expand its sales force to meet the high demand for this unique wound care device.
About Derma Sciences
Derma Sciences is a manufacturer and marketer of advanced wound-care products, with operations based in the US and Canada, and sales worldwide. The company recently launched its MEDIHONEY(TM) Wound & Burn dressings with Active Leptospermum Honey. The Company has also obtained FDA clearance to market and sell its MOBILITY-1(TM) boot and compressor device for the treatment of venous ulcers, lymphedema, and other conditions that require compression therapy. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.
About the
'/>"/>
| SOURCE Derma Sciences, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. 1st EMEA application filed for product using innovative intradermal microinjection system BD Soluvia
2. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
3. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
4. AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair
5. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
6. Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com
7. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
8. LOreal USA Announces Three-Year Support of Womens Dermatologic Society Foundation Community Outreach
9. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
10. American Academy of Dermatology Caught in Pay-for-Play Scandal
11. New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |